Abstract:BackgroundMonosomy of the X chromosome is the most frequent genetic abnormality in human as it is present in approximately 2% of all conceptions, although 99% of these embryos are spontaneously miscarried. In postnatal life, clinical features of Turner syndrome may include typical dysmorphic stigmata, short stature, sexual infantilism, and renal, cardiac, skeletal, endocrine and metabolic abnormalities.Main textTurner syndrome is due to a partial or total loss of the second sexual chromosome, resulting in the development of highly variable clinical features. This phenotype may not merely be due to genomic imbalance from deleted genes but may also result from additive influences on associated genes within a given gene network, with an altered regulation of gene expression triggered by the absence of the second sex chromosome. Current studies in human and mouse models have demonstrated that this chromosomal abnormality leads to epigenetic changes, including differential DNA methylation in specific groups of downstream target genes in pathways associated with several clinical and metabolic features, mostly on autosomal chromosomes. In this article, we begin exploring the potential involvement of both genetic and epigenetic factors in the origin of X chromosome monosomy. We review the dispute between the meiotic and post-zygotic origins of 45,X monosomy, by mainly analyzing the findings from several studies that compare gene expression of the 45,X monosomy to their euploid and/or 47,XXX trisomic cell counterparts on peripheral blood mononuclear cells, amniotic fluid, human fibroblast cells, and induced pluripotent human cell lines. From these studies, a profile of epigenetic changes seems to emerge in response to chromosomal imbalance. An interesting finding of all these studies is that methylation-based and expression-based pathway analyses are complementary, rather than overlapping, and are correlated with the clinical picture displayed by TS subjects.ConclusionsThe clarification of these possible causal pathways may have future implications in increasing the life expectancy of these patients and may provide informative targets for early pharmaceutical intervention.

A Case of Chimeric Turner Syndrome with Normal Reproductive Function

Cytogenetic Analysis of a Patient with Turner Syndrome (45,X/47,XXX/48,XXXX/46,XX)

Cytogenetic diagnosis study of 46 cases of Turner Syndrome

Turner Syndrome Caused by Rare Complex Structural Abnormalities Involving Chromosome X

Chromosomal Abnormalities of Interest in Turner Syndrome: An Update

Prenatal Diagnosis of Turner Syndrome Mosaicism: A Case Report

A case report of a normal fertile woman with 46,XX/46,XY somatic chimerism reveals a critical role for germ cells in sex determination

Identification of a Small Supernumerary Marker Chromosome in a Turner Syndrome Patient with Karyotype mos 46,X,+mar/45,X

A Case of Ankylosing Spondylitis and Ichthyosis Vulgaris in a Turner Syndrome Patient with a Rare Karyotype

Epigenetics in Turner syndrome

A Turner syndrome case associated with dic(Y;22)

Bioinformatic Analysis Identifies Potential Key Genes in the Pathogenesis of Turner Syndrome

Turner Syndrome with Mosaicism of X Chromosome: A Case Report

Mosaic Turner Variant Adult Female Presenting with XO/XY Karyotype

Reproductive health in Turner's syndrome: from puberty to pregnancy

Clinical Analysis of Turner＇s Syndrome

[Genetic analysis of a child with mosaicism Turner syndrome]

Prenatal diagnosis of female monozygotic twins discordant for Turner syndrome: implications for prenatal genetic counselling

SRY-positive 45,X/46,XY karyotype in a phenotypically Turner-like Chinese adolescent female with ovarian dysgerminoma and gonadoblastoma

Lifelong medical challenges and immunogenetics of Turner syndrome

A Rare Unbalanced Y:autosome Translocation in a Turner Syndrome Patient.